Publicacións en colaboración con investigadores/as de University Medical Center Utrecht (53)

2024

  1. A Genome-Wide Association Study Suggests New Susceptibility Loci for Primary Antiphospholipid Syndrome

    Arthritis and Rheumatology, Vol. 76, Núm. 11, pp. 1623-1634

  2. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

  3. Severity and progression of structural hand OA is not associated with progression of structural knee OA: The IMI-APPROACH cohort

    Osteoarthritis and Cartilage Open, Vol. 6, Núm. 3

2023

  1. Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study

    Osteoarthritis and Cartilage Open, Vol. 5, Núm. 4

  2. HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 62, Núm. 7, pp. 2621-2630

  3. Machine-learning predicted and actual 2-year structural progression in the IMI-APPROACH cohort

    Quantitative Imaging in Medicine and Surgery, Vol. 13, Núm. 5, pp. 3298-3306

  4. Quantitative CT of the knee in the IMI-APPROACH osteoarthritis cohort: Association of bone mineral density with radiographic disease severity, meniscal coverage and meniscal extrusion

    Bone, Vol. 168

  5. Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort

    Osteoarthritis and Cartilage, Vol. 31, Núm. 2, pp. 238-248

2022

  1. A new immunometabolic perspective of intervertebral disc degeneration

    Nature Reviews Rheumatology, Vol. 18, Núm. 1, pp. 47-60

  2. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  3. GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohort

    PLoS ONE, Vol. 17, Núm. 3 March

  4. Osteoarthritis endotype discovery via clustering of biochemical marker data

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 5, pp. 666-675

  5. Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort

    Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 147-157

  6. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry

    Annals of the rheumatic diseases, Vol. 81, Núm. 5, pp. 695-709

  7. Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort

    BMC Musculoskeletal Disorders, Vol. 23, Núm. 1

  8. The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort

    Osteoarthritis and Cartilage, Vol. 30, Núm. 8, pp. 1062-1069

  9. WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes

    Laboratory Investigation, Vol. 102, Núm. 9, pp. 989-999

2021

  1. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 707-713

  2. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 10, pp. 1278-1285

  3. An update on the role of leptin in the immuno-metabolism of cartilage

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-16